Schroder Investment Management Group Standard Biotools Inc. Transaction History

Schroder Investment Management Group

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$2.3 - $5.12 $1.85 Million - $4.12 Million	-803,946 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$4.63 - $12.15 $923,022 - $2.42 Million	199,357 Added 32.97%	803,946 $3.79 Million
Q2 2019 Aug 08, 2019	BUY	$11.49 - $14.17 $2.34 Million - $2.89 Million	203,862 Added 50.87%	604,589 $7.45 Million
Q1 2019 May 14, 2019	SELL	$8.47 - $14.36 $851,700 - $1.44 Million	-100,555 Reduced 20.06%	400,727 $5.33 Million
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $3.6 Million - $4.43 Million	501,282 New	501,282 $4.32 Million

143

274M

6.7K

48.7K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $95.2M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.